Eco Animal Health - USDA approval - September 2026

Eco Animal Health announces that the US Department of Agriculture, Centre for Veterinary Biologics (USDA-CVB) has confirmed that Eco Animal Health’s US field safety trial data for its proprietary poultry vaccine, ECOVAXXIN®MS, fulfils the requirement to enable licensing of the product. This represents a major regulatory milestone in the path towards commercial deployment. The Group expects to receive US marketing approval by the end of CY26. Today’s announcement represents an important step towards ECOVAXXIN® MS commercialisation, and follows strong Group performance in FY26. Our Fair Value remains 180p/share.